Last reviewed · How we verify

Epidural analgesia

Peking University First Hospital · Phase 3 active Small molecule

Epidural analgesia delivers pain-relieving medication directly into the epidural space around the spinal cord to block pain signals in a localized region.

Epidural analgesia delivers pain-relieving medication directly into the epidural space around the spinal cord to block pain signals in a localized region. Used for Perioperative pain management, Labor analgesia, Postoperative pain relief.

At a glance

Generic nameEpidural analgesia
Also known asNo other intervention, Epidural Block, ropivicaine, hydromorphone, Naropin
SponsorPeking University First Hospital
Drug classRegional anesthetic technique / Local anesthetic with or without opioid
ModalitySmall molecule
Therapeutic areaPain Management / Anesthesia
PhasePhase 3

Mechanism of action

Epidural analgesia involves injection of local anesthetics and/or opioids into the epidural space, which surrounds the dura mater of the spinal cord. The medication diffuses across the dura to block nerve roots and spinal cord segments, providing regional anesthesia and analgesia without affecting consciousness. This technique is commonly used for perioperative pain management, labor analgesia, and chronic pain conditions.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: